TIMETRICE BENSON: Open Payments
NPI 1780329813 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 49 payments from 18 companies in 2025. Trend: 2023 $139 · 2024 $504 · 2025 $973
Food & beverage: $973
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $160 |
| Corcept Therapeutics | 4 | $106 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| Lilly USA, LLC | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Exact Sciences Corporation | 2 | $51 |
| Dexcom, Inc. | 2 | $43 |
Products named: VRAYLAR, Korlym, REXULTI, MOUNJARO, CAPLYTA, TRELEGY ELLIPTA, Auvelity, QULIPTA.
Industry payments across MI — which companies pay providers there.
